ClinicalTrials.Veeva

Menu

Identification of Corticomedullary Differentiation Along Different Stage of Pregnancy

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Nephropathy

Study type

Observational

Funder types

Other

Identifiers

NCT02193516
MMC1413-0250CTIL

Details and patient eligibility

About

Corticomedullary differentiation (CMD) abnormality (absent/reversed) is a parameter that can indicate possible nephropathy. The evolution of CMD across gestation had not been well established. Devrendt et al demonstrated the presence of CMD in all fetuses older then 20 weeks. In our study we would like to determine the exact timing of it's sonographic visualisation. This is a prospective study recruiting women between 14-24 week gestation during routine ultrasound screening. A midsagittal image of each kidney will be taken by a single sonographer and examined for the presence of the CMD by two other sonographers blinded to gestational age.

Enrollment

330 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant women 14-24 weeks
  • singleton pregnancy
  • Appropriate for gestational age fetuses
  • well dated pregnancy

Exclusion criteria

  • family history of renal disease
  • small /large for gestational age fetuses
  • known structural anomalies
  • unknown dating

Trial contacts and locations

1

Loading...

Central trial contact

Efrat Hadi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems